Month: December 2015

Manel Esteller, a world leader in cancer epigenetics and researcher at IDIBELL, receives National Research Prize 2015

The Government of Catalonia and the Catalan Foundation for Research and Innovation (FCRI) have awarded Manel Esteller, researcher at IDIBELL, the National Research Award 2015. Esteller is an ICREA research professor, director of the Epigenetics and Cancer Biology Program of the Institute of Biomedical Research of Bellvitge since 2008, head of the cancer Epigenetics Group of the center and professor of Genetics at the Department of Physiological Sciences II of the Faculty of Medicine of the University of Barcelona.

ERDF Funds subsidize new scientific equipment for IDIBELL

The Spanish Ministry of Economy and Competitiveness (MINECO) has granted a project to Bellvitge Biomedical Research Institute (IDIBELL) for the purchase of scientific equipment intended for laboratories, platforms and other scientific services with high-level technological instrumentation. The project, which is funded by the European Regional Development Fund (ERDF), has a total cost of € 2.290.725,9 …

ERDF Funds subsidize new scientific equipment for IDIBELL Read More »

UPC students, in collaboration with HUB and IDIBELL present new technologies to improve the treatment of facial paralysis

“Software of image processing as facial neuromuscular therapy in patients with peripheral facial paralysis” is the second project born of the agreement between the Polytechnic University of Catalonia, the University Hospital of Bellvitge (HUB) and IDIBELL to promote biomedical research and technology transfer. On the one hand, the agreement enables UPC students learn about the …

UPC students, in collaboration with HUB and IDIBELL present new technologies to improve the treatment of facial paralysis Read More »

10% of sporadic colon tumors have mutations in the gene AMER1

Sanz-Pamplona R, Lopez-Doriga A, Paré-Brunet L, Lázaro K, Bellido F, Alonso MH, Aussó S, Guinó E, Beltrán S, Castro-Giner F, Gut M, Sanjuan X, Closa A, Cordero D, Morón-Duran FD, Soriano A, Salazar R, Valle L, Moreno V. Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer. Clinical Cancer Research 2015; 21(20):4709-18. doi: 10.1158/1078-0432.CCR-15-0159

IDIBELL is positioned in favor of Open Access policies

The Bellvitge Biomedical Research Institute (IDIBELL) has signed the statement of the League of European Research Universities (LERU) to promote Open Access policies in the dissemination of scientific results. According to the manifesto, European universities allocate a significant portion of their budgets to scientific journals publishers. Hundreds of millions of euro’s. Money which is not …

IDIBELL is positioned in favor of Open Access policies Read More »

Scroll to Top